Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation

Hepatocellular carcinoma (HCC) has a high fatality rate and limited therapeutic options with side effects and low efficacy. Here, we proposed a new anti-HCC approach based on cancer-specific post-transcriptional targeting. To this end, trans-splicing ribozymes from Tetrahymena group I intron were de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Juhyun, Won, Ranhui, Ban, Guyee, Ha Ju, Mi, Sook Cho, Kyung, Young Han, Sang, Jeong, Jin-Sook, Lee, Seong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507181/
https://www.ncbi.nlm.nih.gov/pubmed/26189916
http://dx.doi.org/10.1038/srep12315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507181/
https://www.ncbi.nlm.nih.gov/pubmed/26189916
http://dx.doi.org/10.1038/srep12315

Ejemplares similares